Financials
Financial year 2025
Apotheek Sophie Dewulf from Ieper, company number BE0810644242, closed financial year 2025 with a result of € -2,726 after tax. For that financial year Apotheek Sophie Dewulf recorded a gross margin of € 123,658 and equity of € 171,578. Compared with financial year 2024, the result moved from € 522 to € -2,726. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on November 25, 2025.
€ 171,578
▼ 2% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -2,726
▼ still € 522 profit in 2024
Profit after tax over the fiscal year.
€ 4,910
▼ 23% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 152,978.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 97,769
▲ 3% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 35,620
▼ 15% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 1,043
▼ 94% vs 2024
Loans from banks and other lenders, long and short.
€ 34,972
▲ 7% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 7,176
▼ 28% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 110,465 | € 130,390 | € 126,514 | € 123,658 | ▼ 2% |
| Profit after taxes | € 48,222 | € 18,237 | € 522 | € -2,726 | ▼ € 3,248 |
| Equity | € 185,775 | € 189,762 | € 174,304 | € 171,578 | ▼ 2% |
| Total debts | € 111,424 | € 162,511 | € 152,095 | € 133,192 | ▼ 12% |
| Cash | € 36,646 | € 8,626 | € 6,345 | € 4,910 | ▼ 23% |
| Retained profit | € 167,175 | € 171,162 | € 155,704 | € 152,978 | ▼ 2% |
| Dividend | € 0 | € 14,250 | € 15,980 | € 0 | ▼ 100% |
| Bank debt | € 42,667 | € 68,606 | € 18,707 | € 1,043 | ▼ 94% |
| Balance sheet total | € 297,199 | € 352,272 | € 326,399 | € 304,770 | ▼ 7% |
Key figures of Apotheek Sophie Dewulf, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to Apotheek Sophie Dewulf?
What happened at Apotheek Sophie Dewulf in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 2,726 (▼ € 3,248 vs 2024). Source: NBB ↗
- New establishment in Ieper. KBO
- Start of the company according to the CBE. KBO
In short
From € 48,222 profit in 2022 to € 2,726 loss in 2025.
Paid € 30,019 in corporate taxes since 2022.
Best year ever: 2022, with € 48,222 profit.
Paid out € 30,230 in dividends to the owners in total.
A new publication or filing at Apotheek Sophie Dewulf? We notify you, reason included.
Follow Apotheek Sophie DewulfDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Apotheek Sophie Dewulf are Sophie DEWULF and BREVERFIN BV. The same people are also behind MARNIC. BREVERFIN BV is also behind STO TERRA INVEST, Steenoven Development Fund, VERDE REAL ESTATE, Verde Construct and ACONSTRUCT.
Directors
According to the 2025 annual accounts
Director · represented by Brecht VERMANDER
Also active at: MARNIC, STO TERRA INVEST, Steenoven Development Fund, VERDE REAL ESTATE, Verde Construct, ACONSTRUCT
Establishments
Establishment units
Physical locations of this company
Boterstraat 44
8900 Ieper
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0810.644.242
- VAT number
- BE 0810.644.242
- Registered office
- Boterstraat 44, 8900 Ieper
- Names & denominations
- Apotheek Sophie Dewulf
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 24 March 2009
- Peppol
- Active · Active since 14 Jan 2026
- Activities · NACE
Detailhandel in farmaceutische producten